AzTrials
AzTrials

Psychological WellnessNCT05719129

The Lasting Change Study

An observational study of Psychological Wellness and Resilience, Psychological, run by Stanford University at 1 site in United States.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The study approach is to leverage the most cutting-edge techniques of multi-omics biology, wearable physiology, and digital real-time psychology profiling and using machine learning models to understand the mechanisms underlying the strategies and techniques that enable participants the power to initiate and maintain… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
Date With Destiny (DWD) Seminar
How many people
1,445 participants
Where
1 siteUnited States
Study dates
30 Nov 2022to Dec 2025
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Individuals that voluntarily chose to participate in DWD seminar.

Who may be able to join

  • 18-years-old and older
  • English speaker
  • Live in the US
  • Participate in the DWD seminar (December 2-7, 2022)

Who cannot join

  • Any physical or mental condition that limits the ability to participate in the study (e.g., answering e-questionnaires and wearing an electronic device)
  • Serious active comorbidity or terminal illness
  • Pregnancy
  • Participation in any other clinical study focusing on psychological or behavioral intervention.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Stanford university

    Palo Alto, California, 94305

Other trials in United States

About this study

Official title: The Stanford Lasting Change Study

The study approach is to leverage the most cutting-edge techniques of multi-omics biology, wearable physiology, and digital real-time psychology profiling and using machine learning models to understand the mechanisms underlying the strategies and techniques that enable participants the power to initiate and maintain sustainable behavior change.

Over the years, millions of people worldwide have attended immersive personal development seminars aiming to improve participants' health behaviors and wellness. Nevertheless, there's a scarcity of large-scale studies to assess their effects on behavior change and investigate their mechanism of action. A recent publication by the Science of Behavior Change Program (SOBC), launched by the National Institute of Health (NIH), recognized that: "science has not yet delivered a unified understanding of basic mechanisms of behavior change across a broad range of health-related behaviors, limiting progress in the development and translation of effective and efficacious behavioral intervention." As such, understanding the mechanisms underlying sustainable behavior change is key.

Being tested
Date With Destiny (DWD) Seminar
Medical subject headings
Psychological Well-Being

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Date With Destiny (DWD) SeminarBehavioural

    6 days of immersive seminar

Study groups in NCT05719129
Study groupRoleWhat they receive
DWD participantsIndividuals that voluntarily chose to participate in DWD seminar.
Receives: Behavioral: Date With Destiny (DWD) Seminar
Matched control groupIndividuals that voluntarily chose to from the US population matched by gender, age, education, ethnicity and income

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mental performance biomarker index.

    An algorithm will be used to create an index score using known biomarkers (psychosocial, physiological, and biological) related to participants' personalized mental performance. Higher index scores will indicate a better mental performance index. This outcome is assessed in the DWD group only.

    Measured: one-year

  2. Change from baseline in Oldenburg Burnout Inventory score (OLBI)

    Participant self-report burnout assessed by OBLI survey, a 16-item questionarie assesing disengagement and exhaustion with a score range of 16-64, where higher scores indicate higher burnout; assessed in all participants.

    Measured: baseline through year one

  3. Change from baseline in Percieved Stress Scale score (PSS-10)

    Participant self-report perceived stress assessed by the Perceived Stress Scale (PSS-10), a 10-item questionnaire with a score range of 0-40, where higher scores indicate greater perceived stress; assessed in all participants.

    Measured: baseline through year one

  4. Change from baseline in well-being score.

    Participant self-report well-being assessed by the PERMA-H Profiler, a 23-item questionnaire measuring psychological well-being across five domains: positive and negative emotions, engagement, relationships, meaning, and accomplishment (range 0-10 per item, higher scores indicate greater well-being); assessed in all participants.

    Measured: baseline through year one

  5. Change from baseline in subjective health score.

    Participant self-report subjective health assessed by the health domain in the PERMA-H Profiler (range 0-10 per item, higher scores indicate higher subjective health); assessed in all participants.

    Measured: baseline through year one

Secondary outcomes (10)
  1. Change from baseline in Connor-Davidson Resilience Scale (CD-RISC-10)

    Participant self-report resilience assessed by CD-RISC-10 survey, a 10-item questionarie assesing resilience with a score range of 0 - 40, where higher scores indicate greater resilience; assessed in all participants.

    Measured: baseline through year one

  2. Change from baseline in General Self-Efficacy Scale (GSE-10)

    Participant self-report self-efficacy assessed by GSE-10 survey, a 10-item questionarie assesing self-efficacy with a score range of 0 - 40, where higher scores indicate greater self-efficacy; assessed in all participants.

    Measured: baseline through year one

  3. Change from baseline in Gratitude Questionnaire-Six Item Form (GQ-6)

    Participant self-report gratitude assessed by the GQ-6 survey, a 6-item questionnaire measuring gratitude with a score range of 6-42, where higher scores indicate higher levels of gratitude; assessed in all participants.

    Measured: baseline through year one

  4. Ecological Momentary Assessments (EMAs) score

    EMAs scores rated by participants to assess momentary mood and cognitive states. This outcome is assessed in the DWD group only.

    Measured: baseline through year one

  5. Professional Fulfillment Index (PFI) score

    Participant self-report positive and negative facets of professional life assessed by PFI survey, a 16-item questionarie assesing fulfillment, work exhaustion, and interpersonal disengagement (range 0-4 per item). This outcome is assessed in the DWD group only.

    Measured: baseline through year one

  6. WHO Quality of Life (WHO-QoL-BREF-26) score

    Participant self-report quality of life assessed by the WHO-QoL-BREF-26 questionnaire, a 26-item questionnaire measuring physical health, psychological health, social relationships, and environmental health (each domain scored from 4 to 20, with higher scores indicating better quality of life). This outcome is assessed in the DWD arm only.

    Measured: baseline through year one

  7. Growth-Fixed Mindset score

    Participants self-report mindset assessed by the Growth and Fixed Mindset questionnaire, adapted to a 3-item questionnaire measuring growth/fixed mindset (higher scores indicating a stronger inclination toward a growth mindset). This outcome is assessed in DWD arm only.

    Measured: baseline through year one

  8. Goals attainment score

    Participant self-report goals attainment assessed by the goals achievement survey, a 14-item questionarie assessing participants' attainment of specific goals (range 0-10 per item). This outcome is assessed in the DWD group only.

    Measured: baseline through year one

  9. Human Needs score

    Participant self-report human needs assessed by the human needs survey, a 36-item questionnaire assessing participants' perceptions of their essential needs (range 0-10 per item). This outcome is assessed in the DWD group only.

    Measured: baseline through year one

  10. Participants experiences and 0pinions

    Semi-structered Interviews with participants about their personal experiences and opinions after the workshop. This outcome will be assessed in DWD arm only.

    Measured: Up to 5 years after completion of the intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Feb 2023
  2. Study start30 Nov 2022
  3. Primary completionDec 2025 (estimated)
  4. Study completionDec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
1,445 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05719129
Sponsor's protocol ID
66491, 68645
Status last verified
Nov 2024
First submitted
22 Jan 2023
Last updated
25 Nov 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The data that support the findings of this study will be available from the corresponding authors upon reasonable request. To protect participant privacy, individual-level data are not publicly available due to the sensitive nature of psychological and health-related information. Aggregated data and analysis scripts used to generate the main results and figures will be deposited in a public repository upon publication. Any additional data or materials required to replicate the reported findings that are not included in the public repository will be made available by the corresponding authors upon reasonable request, subject to institutional review board approval for sharing of de-identified data.

Questions about this trial

What is this clinical trial studying?

An observational study of Psychological Wellness and Resilience, Psychological, run by Stanford University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 25 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mental performance biomarker index. (time frame: one-year). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Nov 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in